Type
Business expansion
Country
Czechia
Region
Moravskoslezsko; Moravskoslezsky;
Location of affected unit(s)
Ostrava
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
19 March 2014
Employment effect (start)
Foreseen end date
31 May 2014

Description

PrimeCell Therapeutics, a global hi-tech company focused in the area of cell therapy and tissue engineering, is to create 100 new jobs with the opening a new 4MEDi biotech park in Ostrava in May 2014. With an investment of CZK 702 million, the biotech park will be one of the largest facilities developing and testing medicines derived from human cells in Europe. It is forecast to grow and should employ up to 250 people in the long-term.


Sources

  • 19 March 2014: Hospod├írske noviny

Citation

Eurofound (2014), PrimeCell Therapeutics, Business expansion in Czechia, factsheet number 76732, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76732.